Point72 Asset Management L.P. increased its position in Sotera Health (NYSE:SHC) by 27,071.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,793,324 shares of the company’s stock after purchasing an additional 1,786,724 shares during the period. Point72 Asset Management L.P. owned 0.63% of Sotera Health worth $44,761,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the company. Citigroup Inc. acquired a new position in Sotera Health in the 4th quarter valued at about $26,000. Ancora Advisors LLC acquired a new position in Sotera Health in the 4th quarter valued at about $27,000. American International Group Inc. acquired a new position in Sotera Health in the 1st quarter valued at about $34,000. Acadian Asset Management LLC acquired a new position in Sotera Health in the 1st quarter valued at about $145,000. Finally, Illinois Municipal Retirement Fund acquired a new position in Sotera Health during the 1st quarter worth approximately $208,000. 87.60% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE SHC opened at $22.63 on Thursday. The firm has a fifty day moving average of $23.83. The company has a current ratio of 2.38, a quick ratio of 2.14 and a debt-to-equity ratio of 4.02. The firm has a market cap of $6.40 billion and a P/E ratio of 59.55. Sotera Health has a 12-month low of $21.21 and a 12-month high of $30.38.
Several equities analysts have issued reports on SHC shares. Zacks Investment Research upgraded Sotera Health from a “sell” rating to a “hold” rating in a research report on Wednesday, July 14th. Credit Suisse Group reiterated a “buy” rating and set a $31.00 target price on shares of Sotera Health in a research report on Tuesday, May 25th. Finally, Barclays upped their price target on Sotera Health from $29.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, July 13th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. Sotera Health presently has a consensus rating of “Buy” and an average price target of $31.86.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
Featured Article: Moving Average Convergence Divergence (MACD)
Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NYSE:SHC).
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.